RSG
65
-3
SYY
49
9
AMT
37
3
EFX
30
-8
IRM
41
3
MUR
44
-3
ADP
65
-3
CFG
74
2
ETR
65
2
CB
57
2
K
51
-3
CNX
73
-3
RHI
57
-6
V
64
-2
MCD
52
-5
ICE
59
-3
HSY
31
-6
REGN
38
-2
EMR
71
-3
NOV
52
-5
RSG
65
-3
SYY
49
9
AMT
37
3
EFX
30
-8
IRM
41
3
MUR
44
-3
ADP
65
-3
CFG
74
2
ETR
65
2
CB
57
2
K
51
-3
CNX
73
-3
RHI
57
-6
V
64
-2
MCD
52
-5
ICE
59
-3
HSY
31
-6
REGN
38
-2
EMR
71
-3
NOV
52
-5
Financhill
Back

Citius Oncology Vs. Neurogene Industry Stock Comparison

Sell
1

CTOR
Citius Oncology

Last Price:
1.04
Seasonality Move:
--
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Sell
1
Citius Oncology (CTOR) is a Sell

Is Citius Oncology a Buy, Sell or Hold?

  • The current Citius Oncology [CTOR] share price is $1.06. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CTOR Stock Price Chart

What is Citius Oncology's stock price today?

  • The Citius Oncology share price today is $1.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CTOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 39.23 Sell
Chaikin Money Flow: -20681 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.09 - 1.27) Sell
Bollinger Bands (100): ( - ) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

CTOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.21 Sell
20-day SMA: 1.2 Sell
50-day SMA: 1.31 Sell
200-day SMA: 0 Buy
8-day EMA: 1.17 Sell
20-day EMA: 1.2 Sell
50-day EMA: 1.38 Sell
200-day EMA: 0.12 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

Citius Oncology Earnings Growth & CTOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Citius Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):